Compositions and methods for altering flowering and plant architecture to improve yield potential

Patent metadata

Field	Value
Publication number	US-2024254501-A1
Application number	US-202418584757-A
Country	US
Kind code	A1
Filing date	Feb 22, 2024
Priority date	Oct 19, 2016
Publication date	Aug 1, 2024
Grant date	—

Abstract

The present invention provides recombinant DNA constructs, vectors and molecules useful for attenuating and/or refining the expression of a florigenic FT gene or transgene using targeting sequences of small RNA molecules. Transgenic plants, plant cells and tissues, and plant parts comprising the recombinant constructs, vectors, and molecules are also provided. Transgenic plants comprising a florigenic FT transgene may produce more bolls, siliques, fruits, nuts, or pods per node on the transgenic plant via suppression, relative to a control or wild type plant. Methods are further provided for introducing the recombinant DNA constructs, vectors, and molecules into a plant, and planting transgenic plants in the field including at higher densities. Transgenic plants of the present invention may provide greater yield potential than wild type or control plants.

First claim

What is claimed is:

1 . A recombinant DNA construct comprising a first expression cassette and a second expression cassette, wherein the first expression cassette comprises a polynucleotide sequence encoding a florigenic FT protein operably linked to a first plant expressible promoter, and the second expression cassette comprises a transcribable DNA sequence encoding a RNA molecule comprising a targeting sequence that is at least 80% complementary to at least 15 consecutive nucleotides of the polynucleotide sequence of the first expression cassette, and wherein the transcribable DNA sequence is operably linked to a second plant expressible promoter.

2 . The recombinant DNA construct of claim 1 , wherein the targeting sequence of the RNA molecule is at least 85% complementary to at least 15 consecutive nucleotides of the polynucleotide sequence of the first expression cassette or an mRNA encoded by the polynucleotide sequence of the first expression cassette.

3 . The recombinant DNA construct of claim 1 , wherein the transcribable DNA sequence comprises a sequence that is at least 80% complementary to SEQ ID NO: 65, 68, or 69.

4 . The recombinant DNA construct of claim 1 , wherein the florigenic FT protein comprises an amino acid sequence having at least 60% identity to a sequence selected from the group consisting of SEQ ID NOs: 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, and 30, or a functional fragment thereof.

5 . The recombinant DNA construct of claim 4 , wherein the florigenic FT protein further comprises one or more of the following amino acids: a tyrosine or other uncharged polar or nonpolar residue at the amino acid position of the florigenic FT protein corresponding to amino acid position 85 of SEQ ID NO: 14; a leucine or other nonpolar residue at the amino acid position of the florigenic FT protein corresponding to amino acid position 128 of SEQ ID NO: 14; and a tryptophan or other large nonpolar residue at the amino acid position of the florigenic FT protein corresponding to amino acid position 138 of SEQ ID NO: 14.

6 . The recombinant DNA construct of claim 4 , wherein the florigenic FT protein does not have one or more of the following amino acids: a histidine at the amino acid position corresponding to a lysine or arginine at the amino acid position corresponding to position 85 of SEQ ID NO: 14; a lysine or arginine at the amino acid position corresponding to position 128 of SEQ ID NO: 14; and a serine, aspartic acid, glutamic acid, lysine or arginine at the amino acid position corresponding to position 138 of SEQ ID NO: 14.

7 . The recombinant DNA construct of claim 1 , wherein the polynucleotide sequence is at least 60% identical to a sequence selected from the group consisting of SEQ ID NOs: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, and 29.

8 . The recombinant DNA construct of claim 1 , wherein the first plant expressible promoter comprises a polynucleotide sequence that is at least 70% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63 and 64, or a functional portion thereof.

9 . The recombinant DNA construct of claim 1 , wherein the second plant expressible promoter comprises a polynucleotide sequence that is at least 70% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, or a functional portion thereof.

10 . The recombinant DNA construct of claim 1 , wherein the second plant expressible promoter comprises a polynucleotide sequence that is at least 70% identical to a polynucleotide sequence selected from the group consisting of SEQ ID NOs: 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, and 94, or a functional portion thereof.

11 . The recombinant DNA construct of claim 1 , wherein the first plant expressible promoter is a vegetative stage promoter and the second plant expressible promoter is a late vegetative stage promoter and/or reproductive stage promoter.

12 . The recombinant DNA construct of claim 11 , wherein the first plant expressible promoter is an early vegetative stage promoter.

13 . The recombinant DNA construct of claim 11 , wherein the second plant expressible promoter is a reproductive stage preferred promoter.

14 . The recombinant DNA construct of claim 1 , wherein the first plant expressible promoter initiates detectable expression of the polynucleotide sequence encoding the florigenic FT protein at an earlier developmental stage than the second plant expressible promoter initiates detectable expression of the transcribable DNA sequence.

15 . A transgenic plant comprising an insertion of the recombinant DNA construct of claim 1 into the genome of at least one cell of the transgenic plant.

16 . The transgenic plant of claim 15 , wherein the transgenic plant is soybean.

17 . The transgenic plant of claim 16 , wherein the transgenic soybean plant produces more pods per node than a control plant not having the recombinant DNA construct.

18 . The transgenic plant of claim 15 , wherein the transgenic plant produces more flowers per node than a control plant not having the recombinant DNA construct.

19 . The transgenic plant or part thereof of claim 15 , wherein the transgenic plant produces more seeds, bolls, siliques, fruits, nuts or pods per node of the transgenic plant than a control plant not having the recombinant DNA construct.

20 . The transgenic plant or part thereof of claim 15 , wherein the transgenic plant flowers earlier than a control plant not having the recombinant DNA construct.

21 . The transgenic plant or part thereof of claim 15 , wherein the transgenic plant has more floral racemes per node than a control plant not having the recombinant DNA construct.

22 . A recombinant DNA construct comprising a polynucleotide sequence encoding a florigenic FT protein operably linked to a plant expressible promoter, wherein the polynucleotide sequence comprises a sequence that encodes a target site in a mRNA transcript encoded by the polynucleotide sequence, and wherein the target site of the mRNA transcript is at least 80% complementary to an endogenous RNA molecule.

23 . The recombinant DNA construct of claim 22 , wherein the target site of the mRNA transcript is at least 17 nucleotides in length.

24 . The recombinant DNA construct of claim 22 , wherein the target site of the mRNA transcript is at least 80% complementary to the endogenous RNA molecule.

25 . The recombinant DNA construct of claim 22 , wherein the target site of the mRNA transcript is at least 80% complementary to SEQ ID NO: 95, 96, 97, 103, 104, or 105.

26 . The recombinant DNA construct of claim 22 , wherein the polynucleotide sequence encoding the florigenic FT protein comprises a sequence that is at least at least 80% identical to SEQ ID NO: 98, 99, 100, 101, 106, 107, 108, 109 or 110.

27 . The recombinant DNA construct of claim 22 , wherein the target site of the mRNA transcript is at least 80% identical to SEQ ID NO: 99 or 107.

28 . The recombinant DNA construct of claim 22 , wherein the florigenic FT protein comprises an amino acid sequence having at least 60% identity to a sequence selected f

Assignees

• Monsanto Technology Llc

Inventors

• Brower-Toland Brent
• Dai Shunhong
• Gabbert Karen
• Goldshmidt Alexander
• Howell Miya
• Mcdill Brad
• Ovadya Dan
• Savidge Beth
• Sharma Vijay

Classifications

• Y02A40/146

  Genetically Modified [GMO] plants, e.g. transgenic plants · CPC title

• C12N15/8218

  Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS] · CPC title

• C07K14/415

  from plants · CPC title

• C12N15/8261

  with agronomic (input) traits, e.g. crop yield · CPC title

• C12N15/827 Primary

  Flower development or morphology, e.g. flowering promoting factor [FPF] · CPC title